论文部分内容阅读
慢性肺原性心脏病(以下简称肺心病),为一常见疾病。现在从各地报告的资料来看,住院的频率和住院病死率还是比较高的。因此,尽快的研究出一个比较合理的综合治疗方案,以求提高治疗效果,尽最大努力减少死亡率,是临床工作者的一項当务之急。为此,我们初拟“肺心病治疗合剂”(PHTM)经临床初步观察,疗效尚佳。故愿介绍,以供临床及科研工作者参考。
Chronic pulmonary heart disease (hereinafter referred to as pulmonary heart disease), is a common disease. Now from the information reported around the point of view, the frequency of hospitalizations and in-hospital mortality is still relatively high. Therefore, as soon as possible to develop a more comprehensive treatment programs, in order to improve the treatment effect, make every effort to reduce mortality, is a top priority for clinicians. To this end, we initially proposed “pulmonary heart disease treatment mixture” (PHTM) preliminary clinical observation, the effect is good. It is willing to introduce for clinical and research workers for reference.